United States· US:0172-7313_94a2cdae-e60e-47c4-8bca-8baac9f21b33

Cyclosporine

A ciclosporin product containing cyclosporine, registered in United States by Teva Pharmaceuticals USA, Inc.. The same ATC class is registered in 16 of our 19 countries.

ATC L04AD01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCyclosporineATCL04AD01REGISTER NO.US:0172-7313_94a2cdae…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Ciclosporin is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AD01 (ciclosporin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Ciclosporin · ATC L04AD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ciclosporin costs, country by country.

Normalised to the WHO defined daily dose (0.25 g), the median price runs from $5.61 in Italy to $13.50 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ciclosporin · price per daily dose (0.25 g)

USD · FX 28 Sept 2026

  • CH Switzerland$13.50
  • IT Italy$5.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CYCLOSPORINE
Manufacturer
Teva Pharmaceuticals USA, Inc.
Country
United States (US)
ATC code
L04AD01
ATC class
Ciclosporin
Defined daily dose
0.25 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0172731320
    1 BOTTLE in 1 PACKAGE (0172-7313-20) / 50 mL in 1 BOTTLE
  • ndc11
    0172-7313-20

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1008 interactions on record for ciclosporin.

Graded by severity as the source publishes them — 129 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ciclosporin · interactions on record

1008 records

  • 129 severe
  • 537 moderate
  • 42 minor
  • 245 info

Most severe, free to view

  • CisaprideA03FA02severe
  • LoperamideA07DA03severe
  • EluxadolineA07DA06severe
  • SulfasalazineA07EC01severe

55 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ciclosporin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciclosporin products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Cequa®, Neoimmun
  • Belgium · Neoral-Sandimmun, Sandimmun
  • Bulgaria · Сандимун Неорал
  • Cyprus · Sandimmun Neoral
  • Czechia · Ciclosporin Viatris, Equoral
  • Germany · Cequa, Cicloral
  • Denmark · Ciqorin, Menelri
  • Estonia · Equoral, Sandimmun Neoral
  • Spain · Cequa, Ciqorin
  • Finland · Cequa, Ciqorin
  • France · Cequa, Ciclograft
  • United Kingdom (Northern Ireland) · Capimune, Capsorin
  • Greece · Imunofar, Sandimmun
  • Croatia · Ciklosporin Alkaloid, Equoral
  • Hungary · Sandimmun, Sandimmun Neoral
  • Ireland · Deximune, Neoral
  • Iceland · Ciqorin, Ikervis
  • Italy · Cequa, Ciqorin
  • Liechtenstein · Ikervis, Verkazia
  • Lithuania · Equoral, Sandimmun Neoral
  • Luxembourg · Neoral-Sandimmun, Sandimmun
  • Latvia · Sandimmun Neoral
  • Malta · Deximune, Sandimmun Neoral
  • Netherlands · Cequa, Ciclosporin Teva
  • Norway · Cequa, Ikervis
  • Poland · Cyclaid, Equoral
  • Portugal · Ciclosporina Flica Germed Farmacêutica, Ciclosporina Generis
  • Romania · Cequa, Sandimmun Neoral
  • Sweden · Cequa, Ciklosporin Ivax
  • Slovenia · Sandimmun, Sandimmun Neoral
  • Slovakia · Ciclosporin Viatris, Equoral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c9b53da7-e5d1-45e5-94d1-be599e5e94ad
GET /v1/drugs/c9b53da7-e5d1-45e5-94d1-be599e5e94ad?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "100",
  "substance": "CYCLOSPORINE",
  "productndc": "0172-7313",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA065078",
  "marketing_category": "ANDA"
}

See everything about ciclosporin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.